MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, DVAX has $946,506K in assets. $412,368K in debts. $160,247K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
762.20%
Quick Ratio
693.61%
Cash Ratio
149.99%
Debt to Asset Ratio
43.57%
Assets Breakdown
    • Marketable securities available-...
    • Cash and cash equivalents
    • Inventories
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Convertible notes, net of debt d...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
160,247 99,101
Marketable securities available-for-sale
487,568 514,628
Accounts receivables, net of allowance for doubtful accounts of 0 and 12,313 at september30, 2025 and december31, 2024, respectively
72,359 70,699
Other receivables
962 2,646
Inventories
73,288 75,687
Prepaid expenses and other current assets
19,907 22,951
Total current assets
814,331 785,712
Property and equipment, net
45,855 45,610
Operating lease right-of-use assets
19,904 20,314
Goodwill
2,199 2,200
Other assets, net of allowance for doubtful accounts of 10,970 at september30, 2025
64,217 64,613
Total assets
946,506 918,449
Accounts payable
3,948 2,702
Accrued research and development
6,697 5,459
Accrued liabilities
51,889 65,952
Convertible notes, current portion, net of debt discount of 135 at september30, 2025 (note 7)
40,073 40,020
Other current liabilities
4,232 4,097
Total current liabilities
106,839 118,230
Convertible notes, net of debt discount of 4,034 and 1,646 at september30, 2025 and december31, 2024, respectively (note 7)
220,966 220,752
Long-term portion of lease liabilities
23,985 24,726
Cepi accrual long-term (note 6)
60,337 60,337
Other long-term liabilities
241 242
Total liabilities
412,368 424,287
Common stock 0.001 par value, 278,000 shares authorized at september30, 2025 and december31, 2024 117,364 shares and 125,450 shares issued and outstanding at september30, 2025 and december31, 2024, respectively
117 117
Additional paid-in capital
1,486,947 1,474,046
Accumulated other comprehensive income
800 652
Accumulated deficit
-953,726 -980,653
Total stockholders equity
534,138 494,162
Total liabilities and stockholders equity
946,506 918,449
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$19,907K Inventories$73,288K Other receivables$962K Accounts receivables,net of allowance for...$72,359K Marketable securitiesavailable-for-sale$487,568K Cash and cashequivalents$160,247K Other assets, net ofallowance for doubtful...$64,217K Goodwill$2,199K Operating leaseright-of-use assets$19,904K Property and equipment,net$45,855K Total current assets$814,331K Total assets$946,506K Total liabilities andstockholders equity$946,506K Total stockholdersequity$534,138K Total liabilities$412,368K Accumulated deficit-$953,726K Accumulated othercomprehensive income$800K Additional paid-in capital$1,486,947K Other long-termliabilities$241K Cepi accruallong-term (note 6)$60,337K Long-term portion of leaseliabilities$23,985K Convertible notes, net ofdebt discount of...$220,966K Total currentliabilities$106,839K Common stock 0.001 parvalue, 278,000 shares...$117K Other currentliabilities$4,232K Convertible notes, currentportion, net of debt...$40,073K Accrued liabilities$51,889K Accrued research anddevelopment$6,697K Accounts payable$3,948K

DYNAVAX TECHNOLOGIES CORP (DVAX)

DYNAVAX TECHNOLOGIES CORP (DVAX)